Publications
2024
| Alene Mathurin, Barbara Tafuto, Doreen Lechner. Barriers to pre-exposure prophylaxis use among women: a systematic literature review. (2024) Principles and Practice of Clinical Research, 10(1). Https://Doi.Org/10.21801/ |
| DeMarco B, Ebanks Y, Tafuto B. Digital badges in academia: An educational tool for the clinical research coordinator. Journal of Clinical and Translational Science. Published online 2024:1-16. doi:10.1017/cts.2024.490 |
| Marucci, Marena A., Doreen W. Lechner, And Barbara A. Tafuto. Safety Outcomes Of Low Versus High Dose Imatinib Mesylate In Patients With Advanced, Metastatic, Or Nonresectable Gastrointestinal Stromal Tumors: A Systematic Review. Gastrointestinal Tract 2.1 (2024). |
2023
| Palalay H, Vyas R, Tafuto B. Real-World Effectiveness of mRNA COVID-19 Vaccines In The Elderly During The Delta And Omicron Variants: Systematic Review. World J Metaanal. 2023;11(5):167-180. PMCID: PMC10421623 |
| Miyata BL, Tafuto B, Jose N. Methods and perceptions of success for patient recruitment in decentralized clinical studies. Journal of Clinical and Translational Science. 2023;7(1):e232. doi:10.1017/cts.2023.643 |
| Mosquera, Andrea M, Aleksunes, Lauren M. Engaging Students in Pharmacogenetics: Patient Case Studies Using the PharmGKB Website. CourseSource 10. https://doi.org/10.24918/cs.2023.10 |
2022
| Tafuto B, Vyas R, Pruis T. CTSA Search Solutions: A novel approach to searching CTSA hub website content. J Clin Transl Sci. 2022 Nov 10;6(1):e132. doi: 10.1017/cts.2022.485. PMID: 36756074; PMCID: PMC9879907. |
| Cooper L, Ajaj, M, Kopicko, K. US social media promotion violation trends in a postguidance era. Regulatory Focus. November 2022. |
| Cooper L, Chen J (2022). Changes in Companion Diagnostic Labelling: Implementation of FDA’s April 2020 Guidance for In Vitro CDx Labeling for Specific Oncology Therapeutic Groups. Ther Innov Regul Sci. 56(5):689-697. Doi:10.1007/s43441-022-00422-z. PMID: 35689144. PMCID: PMC9356945. |
2021
| Thaman P, Tafuto B, Gélinas C, Gaur S, Neubauer JA. Thaman P, Tafuto B, Gélinas C, Gaur S, Neubauer JA. The NJ Alliance for Clinical and Translational Science (NJ ACTS) experience: Responding at “Warp Speed” to COVID-19. J Clin Transl Sci. 2022 Apr 4;6(1):e62. doi: 10.1017/cts.2022.383. PMID: 35720969; PMCID: PMC9161045. |
| Cooper L, Lee I, Waldron Lechner D. COVID-19 Pandemic Response Varies by Clinical Trial Sponsor Type. J Clin Transl Sci. 2021 Mar 16;5(1):e111. doi: 10.1017/cts.2021.25. PMID: 34192064; PMCID: PMC8220021. |
| Cooper L, Wo E, Lee I (2021). A 15 Year Review (2006-2020) of Patient-Reported Outcomes (PRO) in United States Oncology Product Labeling and Trends in Sponsor Size and Oncology Experience, Arch Internal Med Res, 5(3): 412-419. |
2020
| Trinh P, Tafuto B, Ebanks Y, Zunaed Z, Lechner DW. Competency-Based Self-Assessment Tools: A Mixed-Methods Retrospective Analysis of Need. Princ Pract Clin Res. 2021 Oct-Dec;7(4):23-26. doi: 10.21801/ppcrj.2021.74.3. PMID: 35415235; PMCID: PMC9000906. |